GAMMA Investing »

Atea Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-03-31 $585 109 5.38

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Ishares Inc Core Msci Emkt Etf (IEMG)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Eli Lilly Common Stock (LLY)
Exxon Mobil Corp Common Stock (XOM)
Vanguard Bd Index Fds Intermed Term Etf (BIV)

View all positions for GAMMA Investing

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Group
Vanguard Capital Management
Bain Capital Life Sciences Investors
Two Sigma Investments
State Street Corporation
Geode Capital Management
Acadian Asset Management
Dimensional Fund Advisors
Renaissance Technologies
Morgan Stanley
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals